medigraphic.com
ISSN 1561-2937 (Print)

2013, Number 3-4

<< Back Next >>

Rev Cubana Cardiol Cir Cardiovasc 2013; 19 (3-4)

Carcinoid Syndrome. Without valvular involvement. A case report

Valdés GM, Mérida AO, Castro AAM, Pérez RT

Language: Spanish
References: 15
Page: 177-181
PDF size: 336.53 Kb.


ABSTRACT

Carcinoid tumors are neuroendocrine malignancies. The malignant carcinoid syndrome usually results from metastases to the liver. Carcinoid heart disease is characterized by fibrous endocardial thickening that involves the right side of the heart. These changes frequently lead to retraction of the leaflets of the tricuspid and pulmonary valves. We report a case without valvular involvement but with high output heart failure.


REFERENCES

  1. Marañón Cabello A. Síndrome carcinoide. En: Farreras P, Rozman C, editores. Farreras-Rozman Medicina Interna. Madrid: Mos-by-Doyma, 1995; 2.143-2.146.

  2. Moertel CG. Gastrointestinal carcinoid tumors and the malignant carcinoid syndrome. En: Sleisenger MH, Fordtran JS, editores. Gastrointestinal disease. Filadelfia: WB Saunders, 1993; 1.363-1.378.

  3. Arghami A, Connolly HM, Abel MD, Schaff HV. Quadruple valve replacement in patients with carcinoid heart disease. J Thorac Cardiovasc Surg 2010;140:1432-4

  4. Cipriano Abad. Tumores cardíacos (II). Tumores primitivos malignos. Tumores metastásicos. Tumor carcinoide. Rev Esp Cardiol 1998; 51: 103-114)

  5. Van Gompel, J., Sippel, R., Warner, T., et al. Gastrointestinal carcinoid tumors: Factors that predict outcome. World J. Surg. 2004; 28: 387.

  6. Sutcliffe, R., Maguire, D., Ramage, J., et al. Management of neuroendocrine liver metastases. Am. J. Surg. 2004; 39:187.

  7. Alegret JM, Subirana MT, Marcuello E, Bayés-Genís A, Ferrés P, Torner M. Afectación valvular tricuspídea y pulmonar en un caso de síndrome carcinoide. Rev Esp Cardiol 1997; 50: 532-534

  8. Castillo JG, Filsoufi F, Rahmanian PB, Anyanwu A, Zacks JS, Warner RR, et al. Early and late results of valvular surgery for carci-noid heart disease. J Am Coll Cardiol. 2008; 51:1507-9.

  9. Botero M, Fuchs R, Paulus DA. Carcinoid Heart Disease: A Case Report and Literature Review. J. Clin. Anesth 2002; 14:57 -63.

  10. Vinik AI, McLeod MK, Shapiro B, Lloyd RV. Clinical features, diagnosis, and localisation of carcinoid tumors and their manage-ment. Gastrointest Clin North Am 1989; 18: 865–96.

  11. Musunuru S, Carpenter JE, Sippel RS, Kunnimalaiyaan M, ChenH . A Mouse Model of Carcinoid Syndrome and Heart Disease. Journal of Surgical Research 2005; 126: 102–105.

  12. Banzali FM Jr, Tiwari AN, Frantz R, D’Attellis N. Valvular Heart Disease Caused by Carcinoid Syndrome: Emphasis on the Use of Intraoperative Transesophageal Echocardiography. Journal of Cardiothoracic and Vascular Anesthesia 2007; 21: 855-857

  13. Silva J, Ribeiro S, Martins SR, Nunes A. Ecocardiografía tridimensional en la cardiopatía carcinoide. Rev Esp Cardiol. 2011; 64(4):342–348.

  14. Mansencal N, McKenna JM, Mitry E, Beauchet A, Pellerin D, Rougier P, et al. Comparison of Prognostic Value of Tissue Doppler Imaging in Carcinoid Heart Disease Versus the Value in Patients With the Carcinoid Syndrome but Without Carcinoid Heart Dis-ease. Am J Cardiol 2010;105:527–531

  15. Yun D, Heywood JT: Metastatic carcinoid disease presenting solely as high – output heart failure. Ann Intern Med 1994;45:120




2020     |     www.medigraphic.com